Steven Davis, MD
Dermatology · San Antonio, TXNPI 1861431025
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (59.6%), food and beverage and education — rather than concentrated in one kind of arrangement. AbbVie accounts for 72.4% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $1,225, more than ten times the $94 reported in 2021. That places this record below the midpoint for dermatology clinicians in TX, where the typical reported total is $4,085.
Across 22 payments — averaging $64.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$172
- Krystal Biotech Inc$86
- Lilly USA, LLC$73
- Optos, Inc.$22
- Botanix SB Inc$22
- plus $17 from 1 others
Across 754 payments — averaging $2557.78 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Incyte Corporation$400K
- Eli Lilly$275K
- AbbVie$263K
- E.r. Squibb & Sons, L.L.C.$224K
- Amgen$198K
- Pfizer$161K
- plus $406K from 14 others
What the payments were for
- Consulting fees$84660%
- Food & beverage$39228%
- Education$18213%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 11 | $1,027 |
| Johnson & Johnson | 2 | $172 |
| Krystal Biotech Inc | 3 | $86 |
| Lilly USA, LLC | 3 | $73 |
| Optos, Inc. | 1 | $22 |
| Botanix SB Inc | 1 | $22 |
| Sanofi | 1 | $17 |
How this compares
$1,420 in reported general payments places this provider in the 30th percentile of 1,098 dermatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 113 | $6,287 |
| Betamethasone Dipropionate | 141 | $5,690 |
| Clobetasol Propionate | 86 | $3,493 |
| Fluocinonide | 75 | $2,916 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 78 | $2,111 |
| Ketoconazole | 91 | $1,670 |
| Desonide | 29 | $1,258 |
| Triamcinolone Acetonide | 101 | $1,179 |
| Metronidazole | 14 | $1,079 |
| Mupirocin | 135 | $992 |
| Doxycycline Hyclate | 50 | $925 |
| Minocycline Hcl | 16 | $903 |
| Hydrocortisone | 156 | $813 |
| Clindamycin Phosphate | 25 | $802 |
| Cephalexin | 59 | $505 |
Paid to pharmacies, not to this prescriber.
Other dermatology in San Antonio
- William CragunSan Antonio$2.2M
- Emily BeckerSan Antonio$1.2M
- Lindsey FinkleaSan Antonio$435K
- John BrowningSan Antonio$351K
- Vivian BucaySan Antonio$241K
- Annabelle GarciaSan Antonio$215K
- Edward LainAustin$2.5M
- Alpesh DesaiHouston$1.6M
- Craig TellerBellaire$1.3M
- Jennifer CatherDallas$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.